Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
For children with acute infective conjunctivitis, topical antibiotics are associated with a shorter duration of conjunctival symptoms, according to a study published online Oct. 4 in JAMA Network Open.
Oct 4, 2022
0
5
When the menopause sets in, many women consider initiating hormonal therapy containing the sex hormone estrogen.
Sep 12, 2022
0
20
Significant improvement in progression free survival and response rate combined with reduced symptoms and better quality of life are reported as outcomes of a new treatment approach for patients with desmoid tumors, which ...
Sep 12, 2022
0
4
For patients with acute decompensated heart failure, the addition of acetazolamide to loop diuretic therapy yields an increased incidence of successful decongestion, according to a study published online Aug. 27 in the New ...
Aug 29, 2022
0
0
The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with asundexian reduced recurrent ischemic stroke and transient ischemic attack (TIA) without increasing ...
Aug 29, 2022
0
4
High-dose vitamin D supplementation in pediatric patients with new-onset type 1 diabetes may reduce complications, according to a study published online Aug. 18 in Frontiers in Endocrinology.
Aug 26, 2022
0
10
For older adults at risk of dementia, regular exercise from light stretching to rigorous aerobics can help slow memory and thinking decline, a new study shows.
Aug 22, 2022
0
35
The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the Aug. 4 issue of the New England Journal of Medicine.
Aug 4, 2022
0
2
COVID rebound, which struck both President Joe Biden and White House Chief Medical Advisor Dr. Anthony Fauci recently, doesn't just happen in those who take Paxlovid, a new study finds.
Aug 3, 2022
1
4
